US Bancorp’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-118,921
| Closed | -$397K | – | 3628 |
|
|
2017
Q4 | $397K | Hold |
118,921
| – | – | ﹤0.01% | 1541 |
|
|
2017
Q3 | $254K | Hold |
118,921
| – | – | ﹤0.01% | 1747 |
|
|
2017
Q2 | $293K | Hold |
118,921
| – | – | ﹤0.01% | 1643 |
|
|
2017
Q1 | $274K | Buy |
118,921
+28,087
| +31% | +$64.7K | ﹤0.01% | 1661 |
|
|
2016
Q4 | $89K | Hold |
90,834
| – | – | ﹤0.01% | 2171 |
|
|
2016
Q3 | $103K | Hold |
90,834
| – | – | ﹤0.01% | 2063 |
|
|
2016
Q2 | $134K | Hold |
90,834
| – | – | ﹤0.01% | 1869 |
|
|
2016
Q1 | $130K | Hold |
90,834
| – | – | ﹤0.01% | 1881 |
|
|
2015
Q4 | $149K | Hold |
90,834
| – | – | ﹤0.01% | 1841 |
|
|
2015
Q3 | $213K | Hold |
90,834
| – | – | ﹤0.01% | 1703 |
|
|
2015
Q2 | $248K | Buy |
+90,834
| New | +$248K | ﹤0.01% | 1671 |
|